JP2014525459A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014525459A5 JP2014525459A5 JP2014528613A JP2014528613A JP2014525459A5 JP 2014525459 A5 JP2014525459 A5 JP 2014525459A5 JP 2014528613 A JP2014528613 A JP 2014528613A JP 2014528613 A JP2014528613 A JP 2014528613A JP 2014525459 A5 JP2014525459 A5 JP 2014525459A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- agent
- compound
- agents
- bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003795 chemical substances by application Substances 0.000 claims description 51
- 150000001875 compounds Chemical class 0.000 claims description 40
- 239000002105 nanoparticle Substances 0.000 claims description 34
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 32
- 239000000032 diagnostic agent Substances 0.000 claims description 27
- 229940039227 diagnostic agent Drugs 0.000 claims description 27
- 125000005647 linker group Chemical group 0.000 claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims description 24
- 229920006395 saturated elastomer Polymers 0.000 claims description 24
- 230000008685 targeting Effects 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 21
- 239000002502 liposome Substances 0.000 claims description 17
- 235000012000 cholesterol Nutrition 0.000 claims description 16
- 229920001223 polyethylene glycol Polymers 0.000 claims description 16
- -1 phosphonic acid compound Chemical class 0.000 claims description 12
- 230000002163 immunogen Effects 0.000 claims description 10
- 150000002632 lipids Chemical class 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 5
- 229940124597 therapeutic agent Drugs 0.000 claims description 5
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 125000000732 arylene group Chemical group 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- 229920005646 polycarboxylate Polymers 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 230000008878 coupling Effects 0.000 claims description 3
- 238000010168 coupling process Methods 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 108091023037 Aptamer Proteins 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 229940123237 Taxane Drugs 0.000 claims description 2
- 239000002246 antineoplastic agent Substances 0.000 claims description 2
- 229960004562 carboplatin Drugs 0.000 claims description 2
- 190000008236 carboplatin Chemical compound 0.000 claims description 2
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims description 2
- 229960004316 cisplatin Drugs 0.000 claims description 2
- 239000002872 contrast media Substances 0.000 claims description 2
- 239000000412 dendrimer Substances 0.000 claims description 2
- 229920000736 dendritic polymer Polymers 0.000 claims description 2
- 229960004679 doxorubicin Drugs 0.000 claims description 2
- 229960002949 fluorouracil Drugs 0.000 claims description 2
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims description 2
- 229960005277 gemcitabine Drugs 0.000 claims description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 claims description 2
- 229960001756 oxaliplatin Drugs 0.000 claims description 2
- 229920001451 polypropylene glycol Polymers 0.000 claims description 2
- 230000002285 radioactive effect Effects 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161529665P | 2011-08-31 | 2011-08-31 | |
| US61/529,665 | 2011-08-31 | ||
| PCT/US2012/053211 WO2013033450A2 (en) | 2011-08-31 | 2012-08-30 | Remote assembly of targeted nanoparticles using h-phosphonate-ene/-yne hydrophosphonylation reactions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014525459A JP2014525459A (ja) | 2014-09-29 |
| JP2014525459A5 true JP2014525459A5 (enExample) | 2015-10-15 |
Family
ID=46832627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014528613A Pending JP2014525459A (ja) | 2011-08-31 | 2012-08-30 | Ｈ−ホスホネート−エン／ｈ−ホスホネート−インヒドロホスホニル化反応を用いた標的化ナノ粒子のリモートアセンブリ |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9216225B2 (enExample) |
| EP (1) | EP2750711A2 (enExample) |
| JP (1) | JP2014525459A (enExample) |
| KR (1) | KR20140064917A (enExample) |
| CN (1) | CN103945869A (enExample) |
| BR (1) | BR112014004716A2 (enExample) |
| CA (1) | CA2845851A1 (enExample) |
| IL (1) | IL231216A0 (enExample) |
| WO (1) | WO2013033450A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9918190B2 (en) * | 2015-02-18 | 2018-03-13 | Cisco Technology, Inc. | Augmenting network device management |
| FR3046728B1 (fr) * | 2016-01-19 | 2020-04-03 | Centre National De La Recherche Scientifique | Nouvelles nanoparticules d'organosilice mesoporeuses, leur methode de preparation et leurs utilisations. |
| JPWO2019009434A1 (ja) * | 2017-07-06 | 2020-07-02 | 学校法人京都薬科大学 | 薬物送達用高分子ミセル |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2940961A (en) * | 1957-08-09 | 1960-06-14 | Eastman Kodak Co | Alkyl 1-acetoxyalkenylphosphonates and polymers thereof |
| US3006945A (en) * | 1960-09-01 | 1961-10-31 | Ethyl Corp | Preparation of organic compounds |
| US3224973A (en) * | 1960-09-01 | 1965-12-21 | Ethyl Corp | Dialkyl hydroxybenzyl phosphonates as antioxidants |
| US3367870A (en) * | 1963-09-12 | 1968-02-06 | Geigy Chem Corp | Method of stabilization with carbonbonded phosphorus derivatives and compositions stabilized thereby |
| US3681481A (en) | 1969-11-12 | 1972-08-01 | Hooker Chemical Corp | Catalytic addition of compounds having a p-h bond to acetylene |
| DE3065878D1 (en) | 1979-07-09 | 1984-01-19 | Elf Aquitaine | Diphosphonic and triphosphonic acid esters, their preparation and applications |
| FR2460958A1 (fr) * | 1979-07-09 | 1981-01-30 | Elf Aquitaine | Nouveaux composes diphosphoniques, utiles a l'extraction des metaux lourds |
| US4820698A (en) * | 1985-11-04 | 1989-04-11 | The Procter & Gamble Company | Antimicrobial agents and process for their manufacture |
| US4798872A (en) * | 1986-04-28 | 1989-01-17 | Ashland Oil, Inc. | Alkylene phosphonate acid ester polyols |
| DE3643684A1 (de) * | 1986-12-20 | 1988-06-30 | Hoechst Ag | Verfahren zur herstellung von halogenierten phosphono-phosphorsaeureestern und ihre verwendung |
| DK637888A (da) * | 1987-11-24 | 1989-05-25 | Hoffmann La Roche | Carboxylsyreestere |
| US5567588A (en) | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
| US5321153A (en) * | 1992-06-15 | 1994-06-14 | Monsanto Company | Process for making chiral alpha-amino phosphonates selected novel chiral alpha-amino phosphonates |
| JPH07140615A (ja) * | 1993-11-12 | 1995-06-02 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー感光材料 |
| JPH07140606A (ja) * | 1993-11-19 | 1995-06-02 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー写真感光材料 |
| DE4410601A1 (de) * | 1994-03-26 | 1995-09-28 | Boehringer Mannheim Gmbh | Neue 2.4-Diphosphonoglutarsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| WO1996024599A1 (en) * | 1995-02-10 | 1996-08-15 | Akzo Nobel N.V. | Synthesis of a hydrocarbylvinyl phosphonic acid hydrocarbyl ester |
| JP2775426B2 (ja) * | 1995-09-14 | 1998-07-16 | 工業技術院長 | 不飽和ホスホン酸エステルの製造方法 |
| GB9613722D0 (en) * | 1996-06-28 | 1996-08-28 | Univ Liverpool | Chemical compounds |
| JP3007984B1 (ja) * | 1999-03-08 | 2000-02-14 | 工業技術院長 | 不飽和ホスホン酸エステルの製造方法 |
| CN1414854B (zh) * | 1999-12-03 | 2015-08-19 | 加利福尼亚大学圣地亚哥分校董事会 | 膦酸酯化合物 |
| JP3610371B2 (ja) * | 2000-03-13 | 2005-01-12 | 独立行政法人産業技術総合研究所 | （α−及び／又はβ−ホルミルエチル）ホスフィンオキシド化合物、（α−及び／又はβ−ホルミルエチル）ホスホン酸エステル化合物とその製造方法 |
| DE10049074A1 (de) | 2000-10-02 | 2002-04-18 | Andreas Kage | Verfahren zur Selektion hochaffin an ein Target bindender Nukleinsäuren |
| GB0025849D0 (en) * | 2000-10-23 | 2000-12-06 | Smithkline Beecham Plc | Novel compounds |
| DE10054218A1 (de) | 2000-11-02 | 2002-05-08 | Basf Ag | Verfahren zur Herstellung von Alkenylphosphonsäure-Derivaten |
| WO2003094851A2 (en) * | 2002-05-11 | 2003-11-20 | Ilex Products, Inc. | 1,1- and 1,2-bisphosphonates as apoliprotein e modulators |
| JP3836395B2 (ja) * | 2002-05-17 | 2006-10-25 | 独立行政法人科学技術振興機構 | アルケニルリン化合物の製造方法 |
| DE102004032781A1 (de) * | 2004-01-23 | 2005-08-11 | Mcs Micro Carrier Systems Gmbh | Bisphosphonsäurederivate |
| JP4314366B2 (ja) * | 2004-02-18 | 2009-08-12 | 独立行政法人産業技術総合研究所 | 含リンブタジエン化合物の製造方法 |
| WO2006078646A2 (en) | 2005-01-18 | 2006-07-27 | Caltagirone Gaetano T | A class of supramolecular drug molecules and methods of identification and use thereof |
| US20100021519A1 (en) * | 2006-04-27 | 2010-01-28 | Narmada Shenoy | Compositions and Methods for Treating or Preventing Diseases of Body Passageways |
| CN1887890A (zh) * | 2006-07-17 | 2007-01-03 | 华中师范大学 | 具有除草活性的α－酰氧基烯基膦酸酯及制备 |
| CN1903862B (zh) * | 2006-07-20 | 2012-10-10 | 华中师范大学 | 具有除草活性的取代甲酰氧基烃基膦酸酯类光学活性异构体及制备 |
| FR2921838A1 (fr) * | 2007-10-05 | 2009-04-10 | Guerbet Sa | Nouveau procede de preparation de nanoparticules recouvertes d'une couche stabilisatrice gem-bisphosphonate couplee a des ligands de biodistribution hydrophile |
| WO2009145263A1 (ja) * | 2008-05-30 | 2009-12-03 | 学校法人東京理科大学 | リン酸オセルタミビルの製造方法及び中間体化合物 |
| US9545452B2 (en) * | 2010-02-08 | 2017-01-17 | Board Of Regents Of The University Of Nebraska | Biomineral and metal binding liposomes, their synthesis, and methods of use thereof |
-
2012
- 2012-08-30 CN CN201280053586.7A patent/CN103945869A/zh active Pending
- 2012-08-30 EP EP12758720.2A patent/EP2750711A2/en not_active Withdrawn
- 2012-08-30 US US13/599,777 patent/US9216225B2/en not_active Expired - Fee Related
- 2012-08-30 KR KR1020147007933A patent/KR20140064917A/ko not_active Withdrawn
- 2012-08-30 CA CA2845851A patent/CA2845851A1/en not_active Abandoned
- 2012-08-30 BR BR112014004716A patent/BR112014004716A2/pt not_active IP Right Cessation
- 2012-08-30 JP JP2014528613A patent/JP2014525459A/ja active Pending
- 2012-08-30 WO PCT/US2012/053211 patent/WO2013033450A2/en not_active Ceased
-
2014
- 2014-02-27 IL IL231216A patent/IL231216A0/en unknown
-
2015
- 2015-11-12 US US14/939,064 patent/US20160060280A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014527071A5 (enExample) | ||
| He et al. | Aptamer-based targeted drug delivery systems: current potential and challenges | |
| Wang et al. | Targeting and delivery of platinum-based anticancer drugs | |
| Wang et al. | Diagnostic imaging and therapeutic application of nanoparticles targeting the liver | |
| JP2013538829A5 (enExample) | ||
| Khan et al. | Nanoparticles for biomedical applications: An overview | |
| Wu et al. | Synergistic cisplatin/doxorubicin combination chemotherapy for multidrug-resistant cancer via polymeric nanogels targeting delivery | |
| Fu et al. | Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer | |
| Lin et al. | Doxorubicin-loaded unimolecular micelle-stabilized gold nanoparticles as a theranostic nanoplatform for tumor-targeted chemotherapy and computed tomography imaging | |
| Prabaharan | Chitosan-based nanoparticles for tumor-targeted drug delivery | |
| Wang et al. | Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery | |
| Kim et al. | Nanomedicine in cancer treatment | |
| US10568970B2 (en) | Theranostic compositions and uses thereof | |
| JP2019523757A5 (enExample) | ||
| Tang et al. | Self-assembly of folic acid dextran conjugates for cancer chemotherapy | |
| CN104582732A (zh) | 治疗癌症的组合物及其制造方法 | |
| JP2014528411A5 (enExample) | ||
| RU2013114474A (ru) | Основанная на наночастицах, нацеленная на опухоли доставка лекарственных средств | |
| JP2012503603A5 (enExample) | ||
| Marrache et al. | Nanocarriers for tracking and treating diseases | |
| JP2016511222A5 (enExample) | ||
| Nurunnabi et al. | Heparin based nanoparticles for cancer targeting and noninvasive imaging | |
| JP2010189373A (ja) | 癌標的性に優れたタンパク質複合体及びその製造方法 | |
| He et al. | Polymer nanoplatforms at work in prostate cancer therapy | |
| Choi et al. | Enabling nanohybrid drug discovery through the soft chemistry telescope |